+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Thyroid Eye Disease Treatments Market - Global Forecast 2026-2032- Product Image
Thyroid Eye Disease Treatments Market - Global Forecast 2026-2032- Product Image
New

Thyroid Eye Disease Treatments Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 193 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5012989
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Thyroid Eye Disease Treatments Market is undergoing significant transformation as innovative therapies and integrated care models redefine clinical pathways. Senior decision-makers are now navigating a complex landscape where advanced treatment modalities and evolving operational demands drive competitive advantage.

Market Snapshot: Thyroid Eye Disease Treatments Market

The global market for Thyroid Eye Disease (TED) treatments is forecasted to grow from USD 2.83 billion in 2025 to USD 2.99 billion in 2026, reaching USD 4.29 billion by 2032 at a compound annual growth rate (CAGR) of 6.14%. This expansion is fueled by the rise of novel immunomodulatory therapies, revised regulatory environments, and broader implementation of sophisticated surgical interventions across major regions. Continued market development is shaped by payer requirements, outcome-based treatment assessments, and the need to accommodate both hospital and outpatient workflows, emphasizing the importance of efficient value demonstration and operational standards.

Scope & Segmentation: Market Structure and Relevance

  • Treatment Types: The market is defined by a wide array of Medical Treatments—including corticosteroids, immunosuppressants, monoclonal antibodies, thyroid hormone regulators, and tyrosine kinase inhibitors—as well as Surgical Treatments such as eyelid procedures, orbital decompression, and strabismus correction. Each pathway is selected based on disease stage, patient profile, and resource availability.
  • Routes of Administration: Intravenous, oral, and topical options deliver flexibility in managing TED across acute and chronic clinical settings. These administration routes support adaptation to patient needs and institutional capabilities.
  • Disease Subtypes: Classification into Type I TED and Type II TED enables targeted and nuanced clinical decisions, supporting optimal therapeutic alignment and resource planning.
  • Diagnostic Tools: Technologies such as blood assays, imaging techniques, orbital ultrasound, and radioactive iodine uptake tests enhance staging accuracy and inform treatment selection at every stage.
  • End-User Settings: Hospitals, outpatient centers, and specialty clinics each represent distinct care environments. These settings influence clinical workflows, infrastructure investment, and care integration initiatives in the TED landscape.
  • Distribution Channels: Both offline and online retail channels play a critical role in providing access to advanced TED therapies and devices, with each affecting compliance and cold-chain management strategies.
  • Geographic Regions: Coverage includes the Americas, Europe, Middle East & Africa, and Asia-Pacific. Each region presents unique regulatory, reimbursement, and adoption patterns, impacting investment planning and commercial rollout.

Key Takeaways for Senior Decision-Makers

  • Integrated, multidisciplinary collaboration between endocrinologists, ophthalmologists, and immunology experts is vital for effective clinical management and improved patient outcomes.
  • Targeted therapies and immunomodulators have shifted focus toward disease modification, requiring rigorous outcome measurement and evidence to substantiate clinical value and patient benefits.
  • Alignment of surgical timing with medical therapies enhances results, offering both functional improvement and better patient experience.
  • Value demonstration strategies are a top priority, with close attention on connecting therapy choice to measurable patient-reported outcomes and durable vision preservation.
  • Personalized care is facilitated by broader diagnostic capabilities, early disease staging, and diversified administration approaches, resulting in improved adherence and more patient-centric protocols.
  • Operational effectiveness hinges on resilient supply networks, effective risk mitigation, and optimized distribution frameworks to maintain uninterrupted access and minimize bottlenecks.

Tariff Impact: United States 2025

Tariff adjustments introduced in 2025 have added commercial complexity to TED treatment markets in the United States. The resultant rise in costs for active ingredients, biologics, devices, and surgical supplies is increasing pressure on margins and extending procurement lead times for many organizations. Companies are responding with supplier diversification, investments in domestic manufacturing, and reshoring strategies to contain costs and maintain competitive positioning. Healthcare providers, including hospitals and clinics, are reviewing capital budgets and reassessing sourcing to ensure continuous delivery of essential diagnostics and therapeutics. Organizations with robust local or vertically integrated supply networks are particularly well-placed to control pricing and meet demand despite tariff-related challenges.

Methodology & Data Sources

The analysis draws from clinical expert interviews, peer-reviewed publications, structured supply chain assessments, and multilayered adoption case studies. All findings are subjected to independent validation by both clinical and operational advisors, with documentation designed to minimize bias and promote actionable, reliable insight.

Thyroid Eye Disease Treatments Market: Why This Report Matters

  • Presents actionable intelligence on evolving TED therapies, diagnostics, and surgical protocols, facilitating informed investment and commercialization planning.
  • Enables leadership teams to understand how evolving market structures, integrated care approaches, and regional innovation trends affect value generation.
  • Provides guidance for building resilient supply chains, engaging payers, and developing validation strategies that optimize outcomes and advance competitive standing.

Conclusion

Strategic integration across clinical, diagnostic, and supply operations will position stakeholders to maximize opportunity in the Thyroid Eye Disease Treatments Market. A connected approach, balancing innovation with operational excellence, supports improved outcomes while supporting sustainable growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Thyroid Eye Disease Treatments Market, by Treatment Type
8.1. Medical Treatment
8.1.1. Corticosteroids
8.1.2. Immunosuppressants
8.1.3. Monoclonal Antibodies
8.1.4. Thyroid Hormone Control
8.1.5. Tyrosine Kinase Inhibitors
8.2. Surgical Treatment
8.2.1. Eyelid Surgery
8.2.2. Orbital Decompression Surgery
8.2.3. Strabismus Surgery
9. Thyroid Eye Disease Treatments Market, by Route of Administration
9.1. Intravenous
9.2. Oral
9.3. Topical
10. Thyroid Eye Disease Treatments Market, by Type
10.1. Type I TED
10.2. Type II TED
11. Thyroid Eye Disease Treatments Market, by Diagnosis
11.1. Blood Test
11.2. Imaging Test
11.3. Orbital Ultrasound
11.4. Radioactive Iodine Uptake Test
12. Thyroid Eye Disease Treatments Market, by End-User
12.1. Hospitals
12.2. Outpatient Centers
12.3. Specialty Clinics
13. Thyroid Eye Disease Treatments Market, by Distribution Channel
13.1. Offline Retail
13.2. Online Retail
14. Thyroid Eye Disease Treatments Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Thyroid Eye Disease Treatments Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Thyroid Eye Disease Treatments Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Thyroid Eye Disease Treatments Market
18. China Thyroid Eye Disease Treatments Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. AbbVie Inc.
19.7. ACELYRIN, INC.
19.8. Amgen Inc.
19.9. argenx SE
19.10. Bausch & Lomb Incorporated
19.11. BioXpress Therapeutics SA
19.12. Cipla Limited
19.13. Dr. Reddy’s Laboratories Ltd.
19.14. Eli Lilly and Company
19.15. F. Hoffmann-La Roche AG
19.16. Genmab A/S
19.17. GlaxoSmithKline PLC
19.18. H. Lundbeck A/S
19.19. Hetero Drugs Limited
19.20. Immunovant, Inc.
19.21. Intas Pharmaceuticals Ltd.
19.22. Johnson & Johnson Services Inc.
19.23. Lupin Limited
19.24. Merck KGaA
19.25. Novartis AG
19.26. Pfizer, Inc.
19.27. Regeneron Pharmaceuticals, Inc.
19.28. Sling Therapeutics, Inc.
19.29. Teva Pharmaceutical Industries Ltd.
19.30. Viridian Therapeutics, Inc.
List of Figures
FIGURE 1. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY CORTICOSTEROIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY THYROID HORMONE CONTROL, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY THYROID HORMONE CONTROL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY THYROID HORMONE CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYROSINE KINASE INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYROSINE KINASE INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYROSINE KINASE INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY EYELID SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY EYELID SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY EYELID SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ORBITAL DECOMPRESSION SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ORBITAL DECOMPRESSION SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ORBITAL DECOMPRESSION SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY STRABISMUS SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY STRABISMUS SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY STRABISMUS SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE I TED, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE I TED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE I TED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE II TED, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE II TED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE II TED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY BLOOD TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY BLOOD TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY BLOOD TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY IMAGING TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY IMAGING TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY IMAGING TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ORBITAL ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ORBITAL ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ORBITAL ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY RADIOACTIVE IODINE UPTAKE TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY RADIOACTIVE IODINE UPTAKE TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY RADIOACTIVE IODINE UPTAKE TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY OUTPATIENT CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY OUTPATIENT CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY OUTPATIENT CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY OFFLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY OFFLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 119. EUROPE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. EUROPE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 121. EUROPE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 122. EUROPE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 123. EUROPE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 124. EUROPE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 125. EUROPE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 126. EUROPE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 127. EUROPE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 137. AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 139. AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 140. AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 141. AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 142. AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 143. AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 144. AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 145. AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 156. ASEAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. ASEAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 158. ASEAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 159. ASEAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 160. ASEAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 161. ASEAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 162. ASEAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 163. ASEAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 164. ASEAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 165. GCC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. GCC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 167. GCC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 168. GCC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 169. GCC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 170. GCC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 171. GCC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 172. GCC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 173. GCC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 183. BRICS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. BRICS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 185. BRICS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 186. BRICS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 187. BRICS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 188. BRICS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 189. BRICS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 190. BRICS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 191. BRICS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 192. G7 THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. G7 THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 194. G7 THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 195. G7 THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 196. G7 THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 197. G7 THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 198. G7 THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 199. G7 THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 200. G7 THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 201. NATO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. NATO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 203. NATO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 204. NATO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 205. NATO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 206. NATO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 207. NATO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 208. NATO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 209. NATO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 210. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 212. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 213. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 214. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 215. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 216. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 217. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 218. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 219. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 220. CHINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 221. CHINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 222. CHINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 223. CHINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 224. CHINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 225. CHINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 226. CHINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 227. CHINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 228. CHINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Thyroid Eye Disease Treatments market report include:
  • Abbott Laboratories
  • AbbVie Inc.
  • ACELYRIN, INC.
  • Amgen Inc.
  • argenx SE
  • Bausch & Lomb Incorporated
  • Biocon Limited
  • BioXpress Therapeutics SA
  • Cipla Limited
  • Dr. Reddy’s Laboratories Ltd.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Genmab A/S
  • GlaxoSmithKline PLC
  • H. Lundbeck A/S
  • Hetero Drugs Limited
  • Immunovant, Inc.
  • Intas Pharmaceuticals Ltd.
  • Johnson & Johnson Services Inc.
  • Lupin Limited
  • Merck KGaA
  • Novartis AG
  • Pfizer, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Sling Therapeutics, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viridian Therapeutics, Inc.

Table Information

Report AttributeDetails
No. of Pages193
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.99 Billion
Forecasted Market Value ( USD ) by 2032 $ 4.29 Billion
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Global Thyroid Eye Disease Treatment Market (2025 Edition): Analysis By Therapeutic Type (Monoclonal Antibodies, Corticosteroids, Vitamins, and Other Therapies), Route of Administration, Distribution Channel: Market Insights and Forecast (2021-2031) - Product Image

Global Thyroid Eye Disease Treatment Market (2025 Edition): Analysis By Therapeutic Type (Monoclonal Antibodies, Corticosteroids, Vitamins, and Other Therapies), Route of Administration, Distribution Channel: Market Insights and Forecast (2021-2031)

  • Report
  • 238 Pages
  • Global
From
Thyroid Eye Disease Market - A Global and Regional Analysis: Focus on Country and Region, 2025-2035 - Product Image

Thyroid Eye Disease Market - A Global and Regional Analysis: Focus on Country and Region, 2025-2035

  • Report
  • Global
From
Graves' Ophthalmopathy - Pipeline Insight, 2025 - Product Image

Graves' Ophthalmopathy - Pipeline Insight, 2025

  • Clinical Trials
  • 80 Pages
  • Global
From
2025 Global Forecast for Thyroid Eye Disease Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Thyroid Eye Disease Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Immunosuppressive Therapy for Eye Diseases Market - Global Forecast 2026-2032 - Product Image

Immunosuppressive Therapy for Eye Diseases Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From

About the Thyroid Eye Disease Treatment Market

Thyroid Eye Disease (TED) is a rare autoimmune disorder that affects the eyes and surrounding tissues. It is caused by an overactive thyroid gland, which produces antibodies that attack the muscles and fatty tissues around the eyes. Symptoms of TED include bulging eyes, double vision, and dry eyes. Treatment for TED typically involves a combination of medications, surgery, and lifestyle changes. Medications used to treat TED include corticosteroids, immunosuppressants, and antithyroid drugs. Surgery may be used to correct double vision, reduce the bulging of the eyes, and improve the appearance of the eyes. Lifestyle changes such as avoiding smoking, reducing stress, and eating a healthy diet can also help manage the symptoms of TED. Companies in the Thyroid Eye Disease Treatment market include Allergan, Novartis, Pfizer, and Regeneron. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.